Do we need to screen our patients for EBV IgG antibody before kidney transplantation?
Seyed Seifollah Beladi Mousavi
1
, *
1 Department of Internal Medicine, Faculty of Medicine, Jundishapur University of Medical Sciences, dr.beladimousavi@ajums.ac.ir, IR.Iran
*
Department of Internal Medicine, Faculty of Medicine, Jundishapur University of Medical Sciences, dr.beladimousavi@ajums.ac.ir, IR.Iran. Tel: 989163068063. Email:
dr.beladimousavi@ajums.ac.ir
Nephro-Urology Monthly: 3 (2) ; 122-124 Article Type: Research Article
Received:
May 16, 2010
Accepted:
July 3, 2010
To Cite:
Beladi Mousavi
S. Do we need to screen our patients for EBV IgG antibody before kidney transplantation?,
Nephro-Urol Mon.
Online ahead of Print
; 3(2):122-124.
Abstract
Background and Aims: Epstein - Barr virus (EBV) can cause serious complications in kidney transplant patients. Current guidelines are recommended that both recipients and donors, be routinely tested for EBV IgG antibody before kidney transplantation and the aim of the study was to evaluate the value of this recommendation.
Material and Methods : In a cross sectional study from February 2009 to March 2010, we evaluated donors and recipients who referred to our kidney transplant center. Routine pretransplante laboratory testes including EBV IgG and IgM antibody were performed.
Results: A total of 112 people, 52 donors (29 male and 23 Female) and 60 recipients (38 male and 22 female) were included in the study. Mean age of donors and recipients were 31.3±6.7 years and 42.1±12.57 years, respectively. Marker of HBV and HCV infections were positive in only 1 and 2 recipients and negative in all of donors. EBV IgG antibody was positive in 70 percent of recipients (n=42) and 52 percent of donors (n=27) but there was no statistically significant difference between them (p =0 .053) and between males and females (p=0.94). EBV IgM antibody was negative in 97 percent of recipients (n=57) and 100 percent of donors (n=67).
Conclusion: The seroprevalence of
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Except where otherwise noted, this work is licensed under
Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments